Literature DB >> 33597276

Evidence for Modulation of Substance Use Disorders by the Gut Microbiome: Hidden in Plain Sight.

Mariana Angoa-Pérez1, Donald M Kuhn2.   

Abstract

The gut microbiome modulates neurochemical function and behavior and has been implicated in numerous central nervous system (CNS) diseases, including developmental, neurodegenerative, and psychiatric disorders. Substance use disorders (SUDs) remain a serious threat to the public well-being, yet gut microbiome involvement in drug abuse has received very little attention. Studies of the mechanisms underlying SUDs have naturally focused on CNS reward circuits. However, a significant body of research has accumulated over the past decade that has unwittingly provided strong support for gut microbiome participation in drug reward. β-Lactam antibiotics have been employed to increase glutamate transporter expression to reverse relapse-induced release of glutamate. Sodium butyrate has been used as a histone deacetylase inhibitor to prevent drug-induced epigenetic alterations. High-fat diets have been used to alter drug reward because of the extensive overlap of the circuitry mediating them. This review article casts these approaches in a different light and makes a compelling case for gut microbiome modulation of SUDs. Few factors alter the structure and composition of the gut microbiome more than antibiotics and a high-fat diet, and butyrate is an endogenous product of bacterial fermentation. Drugs such as cocaine, alcohol, opiates, and psychostimulants also modify the gut microbiome. Therefore, their effects must be viewed on a complex background of cotreatment-induced dysbiosis. Consideration of the gut microbiome in SUDs should have the beneficial effects of expanding the understanding of SUDs and aiding in the design of new therapies based on opposing the effects of abused drugs on the host's commensal bacterial community. SIGNIFICANCE STATEMENT: Proposed mechanisms underlying substance use disorders fail to acknowledge the impact of drugs of abuse on the gut microbiome. β-Lactam antibiotics, sodium butyrate, and high-fat diets are used to modify drug seeking and reward, overlooking the notable capacity of these treatments to alter the gut microbiome. This review aims to stimulate research on substance abuse-gut microbiome interactions by illustrating how drugs of abuse share with antibiotics, sodium butyrate, and fat-laden diets the ability to modify the host microbial community. U.S. Government work not protected by U.S. copyright.

Entities:  

Year:  2021        PMID: 33597276      PMCID: PMC7896134          DOI: 10.1124/pharmrev.120.000144

Source DB:  PubMed          Journal:  Pharmacol Rev        ISSN: 0031-6997            Impact factor:   25.468


  334 in total

1.  Stimulation of nicotine reward and central cholinergic activity in Sprague-Dawley rats exposed perinatally to a fat-rich diet.

Authors:  Irene Morganstern; Olga Lukatskaya; Sang-Ho Moon; Wei-Ran Guo; Jane Shaji; Olga Karatayev; Sarah F Leibowitz
Journal:  Psychopharmacology (Berl)       Date:  2013-07-09       Impact factor: 4.530

2.  Contrasting the Role of xCT and GLT-1 Upregulation in the Ability of Ceftriaxone to Attenuate the Cue-Induced Reinstatement of Cocaine Seeking and Normalize AMPA Receptor Subunit Expression.

Authors:  Amber L LaCrosse; Sinead M O'Donovan; Marian T Sepulveda-Orengo; Robert E McCullumsmith; Kathryn J Reissner; Marek Schwendt; Lori A Knackstedt
Journal:  J Neurosci       Date:  2017-05-11       Impact factor: 6.167

3.  Minocycline attenuates subjective rewarding effects of dextroamphetamine in humans.

Authors:  Mehmet Sofuoglu; Marc Mooney; Thomas Kosten; Andrew Waters; Kenji Hashimoto
Journal:  Psychopharmacology (Berl)       Date:  2010-09-14       Impact factor: 4.530

4.  Obesity-resistant S5B rats showed greater cocaine conditioned place preference than the obesity-prone OM rats.

Authors:  Panayotis K Thanos; Ronald Kim; Jacob Cho; Michael Michaelides; Brenda J Anderson; Stefany D Primeaux; George A Bray; Gene-Jack Wang; John K Robinson; Nora D Volkow
Journal:  Physiol Behav       Date:  2010-08-27

5.  Inhibition of histone deacetylases in rats self-administering cocaine regulates lissencephaly gene-1 and reelin gene expression, as revealed by microarray technique.

Authors:  Lionel Host; Patrick Anglard; Pascal Romieu; Christelle Thibault; Doulaye Dembele; Dominique Aunis; Jean Zwiller
Journal:  J Neurochem       Date:  2010-02-02       Impact factor: 5.372

Review 6.  Glutamate systems in cocaine addiction.

Authors:  Peter W Kalivas
Journal:  Curr Opin Pharmacol       Date:  2004-02       Impact factor: 5.547

Review 7.  Glutamate and reinstatement.

Authors:  Lori A Knackstedt; Peter W Kalivas
Journal:  Curr Opin Pharmacol       Date:  2009-01-20       Impact factor: 5.547

8.  Sequential cocaine-alcohol self-administration produces adaptations in rat nucleus accumbens core glutamate homeostasis that are distinct from those produced by cocaine self-administration alone.

Authors:  Bethany A Stennett; Yasmin Padovan-Hernandez; Lori A Knackstedt
Journal:  Neuropsychopharmacology       Date:  2019-07-02       Impact factor: 8.294

9.  Links of gut microbiota composition with alcohol dependence syndrome and alcoholic liver disease.

Authors:  Veronika B Dubinkina; Alexander V Tyakht; Vera Y Odintsova; Konstantin S Yarygin; Boris A Kovarsky; Alexander V Pavlenko; Dmitry S Ischenko; Anna S Popenko; Dmitry G Alexeev; Anastasiya Y Taraskina; Regina F Nasyrova; Evgeny M Krupitsky; Nino V Shalikiani; Igor G Bakulin; Petr L Shcherbakov; Lyubov O Skorodumova; Andrei K Larin; Elena S Kostryukova; Rustam A Abdulkhakov; Sayar R Abdulkhakov; Sergey Y Malanin; Ruzilya K Ismagilova; Tatiana V Grigoryeva; Elena N Ilina; Vadim M Govorun
Journal:  Microbiome       Date:  2017-10-17       Impact factor: 14.650

10.  Prevention of Diet-Induced Obesity Effects on Body Weight and Gut Microbiota in Mice Treated Chronically with Δ9-Tetrahydrocannabinol.

Authors:  Nina L Cluny; Catherine M Keenan; Raylene A Reimer; Bernard Le Foll; Keith A Sharkey
Journal:  PLoS One       Date:  2015-12-03       Impact factor: 3.240

View more
  5 in total

Review 1.  Through the Looking-Glass: Psychoneuroimmunology and the Microbiome-Gut-Brain Axis in the Modern Antiretroviral Therapy Era.

Authors:  Adam W Carrico; Emily M Cherenack; Leah H Rubin; Roger McIntosh; Delaram Ghanooni; Jennifer V Chavez; Nichole R Klatt; Robert H Paul
Journal:  Psychosom Med       Date:  2022-08-28       Impact factor: 3.864

2.  Chronic Morphine Induces IL-18 in Ileum Myenteric Plexus Neurons Through Mu-opioid Receptor Activation in Cholinergic and VIPergic Neurons.

Authors:  Karan H Muchhala; Eda Koseli; Aravind R Gade; Kareem Woods; Suha Minai; Minho Kang; A Rory McQuiston; William L Dewey; Hamid I Akbarali
Journal:  J Neuroimmune Pharmacol       Date:  2022-02-02       Impact factor: 7.285

Review 3.  The Gut Microbiome and Substance Use Disorder.

Authors:  Jordan T Russell; Yanjiao Zhou; George M Weinstock; Jason A Bubier
Journal:  Front Neurosci       Date:  2021-08-31       Impact factor: 4.677

Review 4.  Recent Advances in Understanding the Structure and Function of the Human Microbiome.

Authors:  Walaa K Mousa; Fadia Chehadeh; Shannon Husband
Journal:  Front Microbiol       Date:  2022-02-03       Impact factor: 5.640

Review 5.  Butyrate and the Intestinal Epithelium: Modulation of Proliferation and Inflammation in Homeostasis and Disease.

Authors:  Pooja S Salvi; Robert A Cowles
Journal:  Cells       Date:  2021-07-14       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.